Project Number 1R42AG062095-01 Agency/Funding Organization NIA Funding Year 2018 View Full Project Details for Production and quality analysis of clinical drug for a novel CNS protein kinase inhibitor therapeutic candidate Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) r. Multi-target Researcher and Organization Principal Investigator WATTERSON, DANIEL MARTIN Principal Investigator First Name DANIEL MARTIN Principal Investigator Last Name WATTERSON Awardee Organization Neurokine Therapeutics LLC Awardee State Pennsylvania Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-18-188: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional) FY Overall Cost $504,907 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
